The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Acquired | Acquired

Total Raised


About C2 Therapeutics

C2 Therapeutics is a medical device company developing Cryoballoon Ablation, which is important in cardiac fibrilation.

C2 Therapeutics Headquarter Location

303 Convention Way # 1

Redwood City, California, 94063,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing C2 Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

C2 Therapeutics is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,001 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,900 items

C2 Therapeutics Patents

C2 Therapeutics has filed 12 patents.

The 3 most popular patent topics include:

  • Cooling technology
  • Engine technology
  • Esophagus disorders
patents chart

Application Date

Grant Date


Related Topics




Refrigerants, Esophagus disorders, Cooling technology, Endoscopy, Digestive system


Application Date


Grant Date



Related Topics

Refrigerants, Esophagus disorders, Cooling technology, Endoscopy, Digestive system



Latest C2 Therapeutics News

Global Digital Therapeutic Devices Market Research Report to 2027 - Featuring BioTelemetry, C2 Therapeutics and Merit Medical Systems Among Others -

May 11, 2022

The Global Digital Therapeutic Devices Market size was estimated at USD 4,485.69 million in 2021, USD 5,298.05 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 18.28% to reach USD 12,287.18 million by 2027. Market Statistics: The report provides market sizing and forecast across seven major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Digital Therapeutic Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Digital Therapeutic Devices Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Digital Therapeutic Devices Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Digital Therapeutic Devices Market? 4. What is the competitive strategic window for opportunities in the Global Digital Therapeutic Devices Market? 5. What are the technology trends and regulatory frameworks in the Global Digital Therapeutic Devices Market? 6. What is the market share of the leading vendors in the Global Digital Therapeutic Devices Market? 7. What modes and strategic moves are considered suitable for entering the Global Digital Therapeutic Devices Market? Market Dynamics Rising focus on preventive healthcare Significant increase in venture capital investments Benefits of digital therapeutics Unexplored therapeutic applications

  • Where is C2 Therapeutics's headquarters?

    C2 Therapeutics's headquarters is located at 303 Convention Way, Redwood City.

  • What is C2 Therapeutics's latest funding round?

    C2 Therapeutics's latest funding round is Acquired.

  • How much did C2 Therapeutics raise?

    C2 Therapeutics raised a total of $25.87M.

  • Who are the investors of C2 Therapeutics?

    Investors of C2 Therapeutics include Pentax Medical.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.